Innovex Medical Co., Ltd.
PrivateLast Round
Series C
Extension
Oct 1, 2021
Est. Valuation
$972.88M
Total Funding Raised
$135.83M
Company Overview
Innovex Medical Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C Extension round in October 2021.
Innovex Medical Co., Ltd. is a medical device company that develops and manufactures minimally invasive interventional medical devices for urology, gastroenterology, pulmonology, gynecology, and general surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovex Medical Co., Ltd. Comparables
Compare Innovex Medical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scivita Medical Technology Co., Ltd. | 90% | |
| Hunan Vathin Medical Instrument Co., Ltd. | 85% | |
| Zhuhai Seesheen Medical Technology Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Innovex Medical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 1, 2021 | ||||
| Series C | Sep 29, 2021 | ||||
| Series B Extension | Jun 1, 2020 | ||||
| Series B | Jul 1, 2019 | ||||
| Series A Extension | May 1, 2019 | ||||
Series A | Jan 1, 2019 |
For institutional investors. Book with your work email.
Innovex Medical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series C |
| Hillhouse Investment | Series C |
| Zhangjiang Shuifeng Innovation Equity Investment Fund | Series C Extension |
| Taikang Life Insurance Company Limited | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 113% MoM, reaching 2.8K.
- May 1, 2025
Monthly visitors increased 156% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Innovex Medical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Innovex Medical Co., Ltd.'s valuation, stock price, and market status.
Is Innovex Medical Co., Ltd. a public or private company?
Innovex Medical Co., Ltd. is a private company.
What is the current stock price of Innovex Medical Co., Ltd.?
Innovex Medical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Innovex Medical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innovex Medical Co., Ltd. worth (valuation)?
Innovex Medical Co., Ltd.'s valuation is estimated at $972.9M based on funding round data.
Can I buy Innovex Medical Co., Ltd. stock?
Innovex Medical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innovex Medical Co., Ltd.'s last funding round?
Innovex Medical Co., Ltd.'s most recent funding round was Series C Extension on October 1, 2021.
Who are the main investors in Innovex Medical Co., Ltd.?
Key investors in Innovex Medical Co., Ltd. include Temasek, Hillhouse Investment, Zhangjiang Shuifeng Innovation Equity Investment Fund, Taikang Life Insurance Company Limited.
Will Innovex Medical Co., Ltd. IPO soon?
No public IPO plans have been announced for Innovex Medical Co., Ltd..
How can I track Innovex Medical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Innovex Medical Co., Ltd.'s shares on secondary markets.